About Quanta Therapeutics
Quanta Therapeutics is a private company based in South San Francisco, California. It has reported $146,344,588 raised in three offerings on Form D since November 2021. Its chief executive is Perry Nisen.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 10, 2023 | May 25, 2023amended Jun 24, 2026 | $76,192,272of $89.0M target | 17 | $4.4M | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Feb 9, 2023 | Feb 17, 2023 | $29,999,993fully sold | 9 | $3.3M | EquityRule 506(b) | Form D ↗ |
| Oct 20, 2021 | Nov 3, 2021 | $40,152,323of $70.1M target | 10 | $4.0M | EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $146,344,588 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Quanta Therapeutics's Form D filed Jun 24, 2026.
MK
PN
CP
MF
YH
DM
RJ
Rajul Jain
Director
Also a director at Capstan Therapeutics, Lb Pharmaceuticals and SonoThera and an executive officer at Vida Ventures.
Earlier filings also listed Samuel Saks (director, last listed Feb 2023), Leonardo Faoro (executive officer, last listed Feb 2023) and Arjun Goyal (director, last listed Feb 2023).